arrow
S

Serena Ruggieri

department of neurosciences, s. camillo-forlanini hospital, rome, italy
H指数:35
被引数:4,341

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Minimal association between Th1-specific responses to COVID-19 vaccines and SARS-CoV-2 breakthrough infections in multiple sclerosis patients receiving disease-modifying therapies

多发性硬化患者在接受疾病修饰疗法时,对COVID-19疫苗的Th1特异性反应与SARS-CoV-2突破性感染之间关联性极低。

2025-10-300
OAAI
Epilepsy in MS and its association with cognitive and psychological burden

多发性硬化中的癫痫及其与认知和心理负担的关联

2025-07-310
OA
Improvement of measured and perceived disability in overweight patients with Multiple Sclerosis trough different patterns of Mediterranean hypocaloric diet

超重多发性硬化患者的测量和感知残疾通过不同模式的低热量地中海饮食得到改善

2025-02-011
PRE
Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study

奥法美南(ocrelizumab)与那他珠单抗(natalizumab)在多发性硬化中的比较疗效、安全性与持续性:一项真实世界、多中心、倾向性评分匹配研究

2025-01-010
OAAI
Anti-RBD Antibody Levels and IFN-γ-Specific T Cell Response Are Associated with a More Rapid Swab Reversion in Patients with Multiple Sclerosis after the Booster Dose of COVID-19 Vaccination
2024-08-190
OAAI
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis
2024-05-231
OAAI
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience

在MS中使用那他珠单抗治疗的不同方案中的治疗调节剂: 意大利的真实世界经验

2024-04-011
OAAI
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria

在多发性硬化诊断标准中加入视神经

2024-01-0917
PRE
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study

在现实环境中评估口服药物对多发性硬化症的治疗反应: 一项MAGNIMS研究

2023-09-296
PRE
Prognostic value of single-subject grey matter networks in early multiple sclerosis
BRAIN
IF11.7
2023-08-298
OAAI
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies
2022-12-1516
OAAI
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults
BRAIN
IF11.7
2022-12-1415
OA
Proinflammatory mucosal-associated invariant CD8+T cells react to gut flora yeasts and infiltrate multiple sclerosis brain

促炎性粘膜相关不变CD8 T细胞对肠道菌群酵母产生反应并浸润多发性硬化大脑

2022-07-2816
OAAI
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study

克拉屈滨在多发性硬化症中有效性和安全性的预测因素: 一项真实世界,多中心,2年随访研究

2022-06-0229
OAAI